Catalyst Pharmaceuticals ... (CPRX)
NASDAQ: CPRX
· Real-Time Price · USD
21.78
-0.11 (-0.50%)
At close: Jun 27, 2025, 3:59 PM
22.15
1.70%
After-hours: Jun 27, 2025, 05:55 PM EDT
-0.50% (1D)
Bid | 21.6 |
Market Cap | 2.66B |
Revenue (ttm) | 534.65M |
Net Income (ttm) | 197.35M |
EPS (ttm) | 1.57 |
PE Ratio (ttm) | 13.87 |
Forward PE | 11.89 |
Analyst | Buy |
Ask | 22.45 |
Volume | 895,186 |
Avg. Volume (20D) | 1,211,269 |
Open | 21.96 |
Previous Close | 21.89 |
Day's Range | 21.68 - 22.06 |
52-Week Range | 14.97 - 26.58 |
Beta | 0.72 |
About CPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Catalyst Pharmaceuticals Inc. is scheduled to release its earnings on Aug 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-2.98%
Catalyst Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
2 months ago
-1.88%
Catalyst Pharmaceuticals shares are trading higher after the company announced that Health Canada accepted its AGAMREE new drug submission with priority review.